The Study of Active Transfer of Plaque Technique for Unprotected Distal Left Main Bifurcation Lesions

Inclusion Criteria: * Patient must be at least ≥18, ≤80 years of age. * Patient has Stable/unstable angina or NSTEMI * Patient has STEMI\>24-hour from the onset of chest pain to admission. * LMb (Medina 0,1,1；1,1,1；0,1,0 ；1,1,0). * Patient is eligible for elective percutaneous coronary intervention (PCI) . * Patient is an acceptable candidate for coronary artery bypass grafting (CABG). * Patient (or legal guardian) understands the trial requirements and treatment procedures and provides written informed consent before any trial-specific tests or procedures are performed; patient is willing to comply with all protocol-required follow-up evaluations Exclusion Criteria: * Patient with STEMI (within 24-hour from the onset of chest pain to admission). * Patient has known allergy to the study stent system or protocol-required concomitant medications that cannot be adequately pre-medicated (everolimus, aspirin, contrast media, acrylic acid, Stainless steel). * Patient has intolerable to dual anti-platelet therapy. * Patient has any other serious medical illness that may reduce life expectancy to less than 12 months. * Patient is pregnant or nursing. * Patient is participating in another clinical trial that has not reached its primary endpoint within 12 months after the index procedure. * Patient with severe calcified lesions needing rotational atherectomy. * Left main In Stent Restenosis. * Investigator consider that patients don't fit to participate in the study.